Changjing Cai
Overview
Explore the profile of Changjing Cai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
659
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Peng Y, Zhang Y, Zeng S, Cai C
J Med Virol
. 2025 Feb;
97(2):e70211.
PMID: 39891594
No abstract available.
2.
Huang K, Han Y, Chen Y, Shen H, Zeng S, Cai C
Mol Cancer
. 2025 Jan;
24(1):7.
PMID: 39789606
Metabolic reprogramming within the tumor microenvironment (TME) is a hallmark of cancer and a crucial determinant of tumor progression. Research indicates that various metabolic regulators form a metabolic network in...
3.
Zhang X, Chen Y, Cai C, Wang Y, Tan J, Fang Z, et al.
Int J Surg
. 2025 Jan;
PMID: 39764584
Detection of biomarkers of breast cancer incurs additional costs and tissue burden. We propose a deep learning-based algorithm (BBMIL) to predict classical biomarkers, immunotherapy-associated gene signatures, and prognosis-associated subtypes directly...
4.
Peng Y, Shen H, Zhang Y, Zeng S, Cai C
J Infect
. 2024 Dec;
90(1):106364.
PMID: 39622388
No abstract available.
5.
Zhang X, Ma J, Chen Y, Deng X, Zhang Y, Han Y, et al.
Mol Ther Oncol
. 2024 Nov;
32(4):200895.
PMID: 39583007
While immunotherapy has marked significant advances in cancer treatment, resistance remains a challenge. The complexity of the tumor microenvironment, particularly the role of B cell subpopulations, is a critical factor...
6.
Cai C, Zhang P, Han Y, Shen H, Zeng S
Lancet Gastroenterol Hepatol
. 2024 Aug;
9(9):787-788.
PMID: 39127073
No abstract available.
7.
Zhou Y, Zhang X, Gao Y, Peng Y, Liu P, Chen Y, et al.
iScience
. 2024 Jul;
27(7):110318.
PMID: 39055918
Colorectal cancer (CRC) exhibits significant heterogeneity, impacting immunotherapy efficacy, particularly in immune desert subtypes. Neuromedin U receptor 1 (NMUR1) has been reported to perform a vital function in immunity and...
8.
Tang Y, Cui G, Liu H, Han Y, Cai C, Feng Z, et al.
Cancer Commun (Lond)
. 2024 May;
44(6):601-636.
PMID: 38715348
Significant developments in cancer treatment have been made since the advent of immune therapies. However, there are still some patients with malignant tumors who do not benefit from immunotherapy. Tumors...
9.
Chen Y, Deng X, Li Y, Han Y, Peng Y, Wu W, et al.
Hepatology
. 2024 Mar;
80(3):536-551.
PMID: 38537130
Background And Aims: Tumor microenvironment (TME) heterogeneity leads to a discrepancy in survival prognosis and clinical treatment response for patients with HCC. The clinical applications of documented molecular subtypes are...
10.
Feng Z, Cui G, Tan J, Liu P, Chen Y, Jiang Z, et al.
Biochim Biophys Acta Mol Basis Dis
. 2024 Jan;
1870(3):167017.
PMID: 38232915
Centromere protein I (CENPI) is an important member of centromeric proteins family, which is crucial to chromosome alignment and segregation. Nevertheless, the interrelation between CENPI expression and tumor progression is...